Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017489
Filing Date
2019-11-14
Accepted
2019-11-14 16:23:30
Documents
74
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 961438
2 ex31-1.htm EX-31.1 15957
3 ex31-2.htm EX-31.2 16736
4 ex32-1.htm EX-32.1 7064
  Complete submission text file 0001493152-19-017489.txt   4483094

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE clsn-20190930.xml EX-101.INS 667295
6 XBRL SCHEMA FILE clsn-20190930.xsd EX-101.SCH 65591
7 XBRL CALCULATION FILE clsn-20190930_cal.xml EX-101.CAL 75992
8 XBRL DEFINITION FILE clsn-20190930_def.xml EX-101.DEF 203070
9 XBRL LABEL FILE clsn-20190930_lab.xml EX-101.LAB 439801
10 XBRL PRESENTATION FILE clsn-20190930_pre.xml EX-101.PRE 309844
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 191220709
SIC: 2834 Pharmaceutical Preparations